tirzepatide going from 2.5 to 5 New Access and Pricing Through Self-Pay Options Switching from semaglutide to tirzepatide

PE-22-28 Safety Considerations# PE-22-28's safety profile is less burdened by mechanism-specific concerns: TREK-1 channels are expressed throughout the body (brain, heart, vasculature, gastrointestinal tract), so systemic TREK-1 blockade could theoretically affect cardiovascular function, pain sensation, and gastrointestinal motility

BMO analysts said last year they expected Lillys drugs to continue to take incremental U.S

GLP-1 medications significantly alter those cues, potentially disrupting recovery work that has taken enormous effort to build

Think of titration like climbing stairs, not jumping between floors

EBioMedicine 40 , 554563 (2019)